journal article·2016-07Open access

The Effects of Crystal Phase and Particle Morphology of Calcium Phosphates on Proliferation and Differentiation of Human Mesenchymal Stromal Cells

Charlène Danoux, Daniel Pereira, Nicola Döbelin, Christoph Stähli, Jake Barralet, Clemens van Blitterswijk, Pamela Habibovic

Advanced Healthcare Materials· Volume 5· Issue 14

Abstract

Calcium phosphate (CaP) ceramics are extensively used for bone regeneration; however, their clinical performance is still considered inferior to that of patient's own bone. To improve the performance of CaP bone graft substitutes, it is important to understand the effects of their individual properties on a biological response. The aim of this study is to investigate the effects of the crystal phase and particle morphology on the behavior of human mesenchymal stromal cells (hMSCs). To study the effect of the crystal phase, brushite, monetite, and octacalcium phosphate (OCP) are produced by controlling the precipitation conditions. Brushite and monetite are produced as plate‐shaped and as needle‐shaped particles, to further investigate the effect of particle morphology. Proliferation of hMSCs is inhibited on OCP as compared to brushite and monetite in either morphology. Brushite needles consistently show the lowest expression of most osteogenic markers, whereas the expression on OCP is in general high. There is a trend toward a higher expression of the osteogenic markers on plate‐shaped than on needle‐shaped particles for both brushite and monetite. Within the limits of CaP precipitation, these data indicate the effect of both crystal phase and particle morphology of CaPs on the behavior of hMSCs.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Periodontal Regeneration and Treatments · Dental Implant Techniques and Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Tissue Regeneration University of Twente P.O. Box 217 7500 AE Enschede The Netherlands

MERLN Institute for Technology‐Inspired Regenerative Medicine Maastricht University P.O. Box 616 6200 MD Maastricht The Netherlands

RMS Foundation P.O. Box 203 2544 Bettlach Switzerland

Institute of Geological Sciences University of Bern Baltzerstrasse 1‐3 3012 Bern Switzerland

Faculty of Dentistry McGill University 3640 University Street Montreal QC H3 A 2B2 Canada

Funding

TeRM Smart Mix Program of the Netherlands Ministry of Education, Culture, and Science

References (42)

Show source-provided references
1. 10.1017/CBO978113902608610.1017/CBO9781139026086 ↗
2. 10.1038/srep1077810.1038/srep10778 ↗
3. 10.1116/1.58860510.1116/1.588605 ↗
4. 10.5618/bio.2011.v1.n1.110.5618/bio.2011.v1.n1.1 ↗
5. 10.1016/j.mattod.2015.10.00810.1016/j.mattod.2015.10.008 ↗
6. 10.1016/j.actbio.2011.03.02710.1016/j.actbio.2011.03.027 ↗
7. 10.1002/adma.20150458910.1002/adma.201504589 ↗
8. 10.1016/j.actbio.2015.02.00310.1016/j.actbio.2015.02.003 ↗
9. 10.1177/1045441192003001060110.1177/10454411920030010601 ↗
10. Elliot J. C. · 1994
11. 10.1016/j.actbio.2011.08.00510.1016/j.actbio.2011.08.005 ↗
12. 10.1038/1961050a010.1038/1961050a0 ↗
13. 10.1016/j.bone.2006.02.05910.1016/j.bone.2006.02.059 ↗
14. 10.1016/j.actbio.2010.04.00210.1016/j.actbio.2010.04.002 ↗
15. 10.1016/S0142-9612(99)00043-510.1016/S0142-9612(99)00043-5 ↗
16. 10.1016/j.colsurfa.2009.03.04610.1016/j.colsurfa.2009.03.046 ↗
17. 10.1098/rsta.2005.168510.1098/rsta.2005.1685 ↗
18. 10.1016/0022-0248(91)90376-G10.1016/0022-0248(91)90376-G ↗
19. 10.1016/0022-0248(84)90220-310.1016/0022-0248(84)90220-3 ↗
20. 10.1016/j.jascer.2014.01.00410.1016/j.jascer.2014.01.004 ↗
21. 10.1007/978-1-4899-1400-2_1810.1007/978-1-4899-1400-2_18 ↗
22. 10.1002/jbm.a.1029110.1002/jbm.a.10291 ↗
23. 10.1007/978-1-4615-5801-910.1007/978-1-4615-5801-9 ↗
24. 10.1039/c3ib40027a10.1039/c3ib40027a ↗
25. 10.1002/jor.2043010.1002/jor.20430 ↗
26. 10.1002/jbm.a.3215610.1002/jbm.a.32156 ↗
27. 10.1089/ten.tea.2007.033910.1089/ten.tea.2007.0339 ↗
28. 10.1016/j.biomaterials.2012.01.02010.1016/j.biomaterials.2012.01.020 ↗
29. 10.1016/0169-6009(92)90750-810.1016/0169-6009(92)90750-8 ↗
30. 10.1161/01.RES.0000234909.24367.a910.1161/01.RES.0000234909.24367.a9 ↗
31. 10.1007/s10856-016-5666-910.1007/s10856-016-5666-9 ↗
32. 10.1023/B:JMSM.0000046394.53153.2110.1023/B:JMSM.0000046394.53153.21 ↗
33. 10.1016/j.cytogfr.2009.10.01810.1016/j.cytogfr.2009.10.018 ↗
34. 10.1006/cbir.1994.108810.1006/cbir.1994.1088 ↗
35. 10.1007/BF0089982510.1007/BF00899825 ↗
36. 10.1107/S160057671501468510.1107/S1600576715014685 ↗
37. Bergmann J. · Comm. Powder Diffract. (IUCr) · 1998 · 20 · 5
38. 10.1039/j1971000372510.1039/j19710003725 ↗
39. 10.1107/S056774087200322X10.1107/S056774087200322X ↗
40. 10.1007/BF0119431510.1007/BF01194315 ↗
41. 10.1089/ten.2005.051310.1089/ten.2005.0513 ↗
42. 10.1089/ten.tea.2009.034110.1089/ten.tea.2009.0341 ↗